Keros Therapeutics, Inc. (KROS)

19.26 -0.27 (-1.38%) USD  |  NASDAQ  |  Jan 15, 16:00
19.27 +0.01 (+0.05%) After-Hours: 20:00
More

Keros Therapeutics EBIT (TTM)

EBIT (TTM) Chart

View EBIT (TTM) for KROS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBIT (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBIT Definition

View EBIT Definition
Start Trial

EBIT is an acronym for earnings before interest and taxes.

Read full definition.

EBIT (TTM) Range, Past 5 Years

View EBIT (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBIT (TTM) Benchmarks

View EBIT (TTM) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Pfizer Inc. Upgrade
Innoviva, Inc. Upgrade
Ocugen, Inc. Upgrade
Bionano Genomics, Inc. Upgrade